CureVac SE Bunyavirales vaccine patent application

← USPTO Patent Applications

BUNYAVIRALES VACCINE

Application US20260091101A1 Kind: A1 Apr 02, 2026

Assignee

CureVac SE

Inventors

Benjamin PETSCH, Edith JASNY

Abstract

The present invention is directed to an artificial nucleic acid, particularly to an artificial RNA, and to polypeptides suitable for use in treatment or prophylaxis of an infection with a virus of the order Bunyavirales, particularly Severe fever with thrombocytopenia syndrome virus (SFTSV), Rift Valley fever virus (RVFV), or Crimean-Congo hemorrhagic fever virus (CCHFV), or a disorder related to such an infection. The present invention further concerns a Bunyavirales vaccine, particularly a SFTSV, RVFV, or CCHFV vaccine. The present invention is directed to an artificial nucleic acid, polypeptides, compositions and vaccines comprising the artificial nucleic acid or the polypeptides. The invention further concerns a method of treating or preventing a disorder or a disease, first and second medical uses of the artificial nucleic acid, polypeptides, compositions and vaccines. Further, the invention is directed to a kit, particularly to a kit of parts, comprising the artificial nucleic acid, polypeptides, compositions and vaccines.

CPC Classifications

A61K 39/12 A61K 9/0019 C12N 7/00 A61K 39/00 A61K 2039/53 C12N 2760/12034 C12N 2760/12234

Filing Date

2025-08-04

Application No.

19290290

View original document →